Skip to content
MedsAcross

Alternatives

Alternatives to Jaythari 36 mg tablet

3 other presentations of Deflazacort 36 mg tablet

There are 3 alternatives to this medicine in the catalogue: the same active ingredient (Deflazacort), strength (36 mg) and dosage form (tablet) from 3 other makers or registers. The table compares packs, storage, lead time, documents and availability.

Side by side

The first row is the medicine you came from.

MedicineManufacturerRegisterPacksStorageLead timeDocumentsAvailability
Jaythari 36 mg tabletThis pageOralZydus LifesciencesIndiaUS FDA1 bottle, 1 bottleStore at 20º to 25ºC (68º to 77ºF), excursions permitted to 15° to 30°C (59° to 86°F).On request—Available on request
Deflazacort 36 mg tabletOral—US FDA30 tablets, 1 bottleStore at 20º to 25ºC (68º to 77ºF), excursions permitted to 15° to 30°C (59° to 86°F).On request—Available on request
Emflaza 36 mg tabletOralPTC TherapeuticsUS FDA30 tabletsStore at 20°C to 25°C (68°F to 77°F). Excursion permitted between 15°C to 30°C (59°F to 86°F). See USP controlled room temperature.On request—Available on request
Kymbee 36 mg tabletOralUpsher-Smith LaboratoriesUS FDA1 bottleStore at 20° to 25°C (68° to 77°F), excursion permitted to 15° to 30°C (59° to 86°F).On request—Available on request

Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Back to Jaythari 36 mg tablet

Not sure which maker to choose?

Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.